Denovo Sciences
Denovo Sciences uses AI to design novel therapeutic molecules for targets with limited data, accelerating early-stage drug discovery. Its proprietary denovo Platform applies reinforcement learning and molecular simulations to explore chemical space, design synthetically accessible compounds, and optimize multiparameter properties. The platform is target-agnostic and can generate candidates against proteins or nucleic acids, including multitarget (polypharmacological) molecules for complex diseases. Denovo partners with academic labs, biotech, and pharmaceutical companies through co-development and drug discovery services. Core technologies include AI, machine learning, reinforcement learning, and computational chemistry.
Denovo Sciences
Denovo Sciences uses AI to design novel therapeutic molecules for targets with limited data, accelerating early-stage drug discovery. Its proprietary denovo Platform applies reinforcement learning and molecular simulations to explore chemical space, design synthetically accessible compounds, and optimize multiparameter properties. The platform is target-agnostic and can generate candidates against proteins or nucleic acids, including multitarget (polypharmacological) molecules for complex diseases. Denovo partners with academic labs, biotech, and pharmaceutical companies through co-development and drug discovery services. Core technologies include AI, machine learning, reinforcement learning, and computational chemistry.